Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
41 studies found for:    HYPERLIPIDEMIA, FAMILIAL COMBINED
Show Display Options
Rank Status Study
1 Unknown  Phase 3 Study to Evaluate the Efficacy and Safety of Omega-3-acids Ethylesters 90 in Type Ⅱb Hyperlipidemia
Condition: Hyperlipidemia, Familial Combined
Interventions: Drug: Atorvastatin 20mg;   Drug: Omega-3-acids ethylesters 90 4g;   Other: Placebo(Omega-3-acids ethylesters 90)
2 Completed Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol
Conditions: Hypercholesterolemia;   Hyperlipidemia, Familial Combined
Interventions: Drug: colesevelam HCl tablets and fenofibrate tablets;   Drug: fenofibrate tablets and Welchol placebo tablets
3 Completed
Has Results
Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)
Condition: Mixed Hyperlipidemia
Interventions: Drug: MK-0524A;   Drug: Atorvastatin;   Drug: Simvastatin
4 Completed Understanding the Genetic Basis of Familial Combined Hyperlipidemia in Mexican Individuals
Conditions: Hyperlipidemia, Familial Combined;   Coronary Disease
Intervention:
5 Completed
Has Results
Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)
Conditions: Primary Hypercholesterolemia;   Mixed Hyperlipidemia
Interventions: Drug: SCH 900271 15mg;   Drug: SCH 900271;   Drug: Placebo
6 Unknown  Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid
Condition: Mixed Hyperlipidemia
Interventions: Drug: Atorvastatin 10mg, fenofibric acid 135mg;   Drug: atorvastatin 20mg
7 Terminated Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.
Condition: Mixed Hyperlipidemia
Interventions: Drug: torcetrapib/atorvastatin;   Drug: atorvastatin
8 Recruiting Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin
Condition: Mixed Hyperlipidemia
Interventions: Drug: Atorvastatin 20mg;   Drug: Fenofibrate 160mg;   Other: Placebo (Fenofibrate 160 mg)
9 Completed Human Lipoprotein Pathophysiology - Subproject: Genetics of Familial Combined Hyperlipidemia
Conditions: Atherosclerosis;   Cardiovascular Diseases;   Heart Diseases;   Hypercholesterolemia;   Hyperlipidemia, Familial Combined
Intervention:
10 Completed Lipid Efficacy Study (0524B-022)(COMPLETED)
Conditions: Primary Hypercholesterolemia;   Mixed Hyperlipidemia
Interventions: Drug: niacin (+) laropiprant (+) simvastatin;   Drug: Comparator: niacin (+) laropiprant;   Drug: Comparator: simvastatin
11 Completed Lipid Efficacy/Tolerability Study (0524A-020)
Conditions: Primary Hypercholesterolaemia;   Mixed Hyperlipidaemia
Interventions: Drug: niacin (+) laropiprant;   Drug: ER-niacin
12 Completed A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)
Conditions: Hyperlipidemia;   Hypercholesterolemia;   Hypertriglyceridemia
Intervention: Drug: ezetimibe (+) simvastatin
13 Withdrawn Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors
Conditions: Cardiovascular Diseases;   Hyperlipidemia
Interventions: Drug: ezetimibe/simvastatin 10/20 mg + placebo;   Drug: ezetimibe/simvastatin 10/20 mg + MK0524A
14 Unknown  Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed Hyperlipidemia
Condition: Dyslipidemia
Interventions: Drug: High-dose rosuvastatin;   Drug: Statin plus fenofibrate;   Drug: Statin plus niacin ER/laropiprant
15 Completed Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)
Conditions: Hypercholesterolemia;   Hypertriglyceridemia
Interventions: Drug: MK0653, ezetimibe;   Drug: Comparator: fenofibrate monotherapy
16 Completed Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)
Conditions: Hypercholesterolemia;   Hypertriglyceridemia
Interventions: Drug: MK0653, ezetimibe;   Drug: Comparator: fenofibrate monotherapy
17 Completed
Has Results
A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED)
Conditions: Primary Hypercholesterolemia;   Mixed Hyperlipidemia
Interventions: Drug: niacin (+) laropiprant;   Drug: Comparator: aspirin;   Drug: Comparator: clopidogrel;   Drug: Comparator: laropiprant;   Drug: Comparator: placebo
18 Completed A Pilot Study to Evaluate the Lipid Effects of TRIA-662
Conditions: Hypertriglyceridemia;   Mixed Hyperlipidemia
Interventions: Drug: TRIA-662;   Drug: Placebo
19 Completed Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care
Conditions: Hyperlipidemia;   Mixed Hyperlipidemia;   Dyslipidemia
Intervention: Drug: Niacin Extended Release/Lovastatin
20 Withdrawn Genomic Dissection of a QTL Affecting the Lipid Profile
Conditions: Cardiovascular Diseases;   Heart Diseases;   Obesity;   Hyperlipidemia, Familial Combined
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.